14.
1. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev. (1999)
20:876–913. doi: 10.1210/edrv.20.6.0385
2. Cho YM, Merchant CE, Kieffer TJ. Targeting the glucagon receptor
family for diabetes and obesity therapy. Pharmacol Ther. (2012) 135:247–
78. doi: 10.1016/j.pharmthera.2012.05.009
3. Kieffer TJ, McIntosh CH, Pederson RA. Degradation of glucose-dependent
insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro
and in vivo by dipeptidyl peptidase IV. Endocrinology. (1995) 136:3585–
96. doi: 10.1210/endo.136.8.7628397
4. Ugleholdt R, Poulsen ML, Holst PJ, Irminger JC, Orskov C, Pedersen
J, et al. Prohormone convertase 1/3 is essential for processing of the
glucose-dependent insulinotropic polypeptide precursor. J Biol Chem. (2006)
281:11050–7. doi: 10.1074/jbc.M601203200
5. Fujita Y, Asadi A, Yang GK, Kwok YN, Kieffer TJ. Differential processing
of pro-glucose-dependent insulinotropic polypeptide in gut. Am J Physiol
Gastrointest Liver Physiol. (2010) 298:G608–14. doi: 10.1152/ajpgi.00024.2010
6. Campbell
JE,
Drucker
DJ.
Pharmacology,
physiology,
and
mechanisms of incretin hormone action. Cell Metab. (2013)
17:819–37. doi: 10.1016/j.cmet.2013.04.008
7. Fujita Y, Wideman RD, Asadi A, Yang GK, Baker R, Webber T, et al. Glucosedependent insulinotropic polypeptide is expressed in pancreatic islet alphacells and promotes insulin secretion. Gastroenterology. (2010) 138:1966–
75. doi: 10.1053/j.gastro.2010.01.049
8. Traub S, Meier DT, Schulze F, Dror E, Nordmann TM, Goetz N,
et al. Pancreatic α cell-derived glucagon-related peptides are required for
β cell adaptation and glucose homeostasis. Cell Rep. (2017) 18:3192–
203. doi: 10.1016/j.celrep.2017.03.005
9. Yanagimachi T, Fujita Y, Takeda Y, Honjo J, Sakagami H, Kitsunai H, et al.
Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in
plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects. Mol
Metab. (2017) 6:226–31. doi: 10.1016/j.molmet.2016.12.009
10. Harano Y, Miyawaki T, Nabiki J, Shibachi M, Adachi T, Ikeda M,
et al. Development of cookie test for the simultaneous determination of
glucose intolerance, hyperinsulinemia, insulin resistance and postprandial
dyslipidemia. Endocr J. (2006) 53:173–80. doi: 10.1507/endocrj.53.173
11. Kaku H, Tajiri Y, Yamada K. Anorexigenic effects of miglitol in concert with
the alterations of gut hormone secretion and gastric emptying in healthy
subjects. Horm Metab Res. (2012) 44:312–18. doi: 10.1055/s-0032–1304563
12. Tsuchimochi W, Ueno H, Yamashita E, Tsubouchi C, Sakoda H, Nakamura
S, et al. Teneligliptin improves glycemic control with the reduction of
postprandial insulin requirement in Japanese diabetic patients. Endocr J.
(2015) 62:13–20. doi: 10.1507/endocrj.EJ14–0393
13. Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T,
et al. Secretion of glucose-dependent insulinotropic polypeptide in patients
Frontiers in Endocrinology | www.frontiersin.org
15.
16.
17.
18.
19.
20.
21.
with type 2 diabetes: systematic review and meta-analysis of clinical studies.
Diabetes Care. (2013) 36:3346–52. doi: 10.2337/dc13–0465
Calanna S, Christensen M, Holst JJ, Laferrère B, Gluud LL, Vilsbøll T, et al.
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus:
systematic review and meta-analyses of clinical studies. Diabetologia. (2013)
56:965–72. doi: 10.1007/s00125–013-2841–0
Cho YM, Fujita Y, Kieffer TJ. Glucagon-like peptide-1: glucose
homeostasis and beyond. Annu Rev Physiol. (2014) 76:535–
59. doi: 10.1146/annurev-physiol-021113–170315
Diakogiannaki E, Gribble FM, Reimann F. Nutrient detection
by incretin hormone secreting cells. Physiol Behav. (2012)
106:387–93. doi: 10.1016/j.physbeh.2011.12.001
Gniuli D, Calcagno A, Dalla Libera L, Calvani R, Leccesi L, Caristo ME,
et al. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic
polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats.
Diabetologia. (2010) 53:2233–40. doi: 10.1007/s00125–010-1830–9
Iwasaki K, Harada N, Sasaki K, Yamane S, Iida K, Suzuki K, et al. Free fatty
acid receptor GPR120 is highly expressed in enteroendocrine K cells of the
upper small intestine and has a critical role in GIP secretion after fat ingestion.
Endocrinology. (2015) 156:837–46. doi: 10.1210/en.2014–1653
Yabe D, Kuroe A, Watanabe K, Iwasaki M, Hamasaki A, Hamamoto
Y, et al. Early phase glucagon and insulin secretory abnormalities,
but not incretin secretion, are similarly responsible for hyperglycemia
after ingestion of nutrients. J Diabetes Complications. (2015) 29:413–
21. doi: 10.1016/j.jdiacomp.2014.12.010
Højberg PV, Vilsbøll T, Zander M, Knop FK, Krarup T, Vølund A, et al. Four
weeks of near-normalization of blood glucose has no effect on postprandial
GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness
to a meal in patients with Type 2 diabetes. Diabet Med. (2008) 25:1268–
75. doi: 10.1111/j.1464–5491.2008.02579.x
Miyachi A, Murase T, Yamada Y, Osonoi T, Harada K. Quantitative analytical
method for determining the levels of gastric inhibitory polypeptides GIP1–42
and GIP3–42 in human plasma using LC-MS/MS/MS. J Proteome Res. (2013)
12:2690–9. doi: 10.1021/pr400069f
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Yanagimachi, Fujita, Takeda, Honjo, Yokoyama and Haneda.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
April 2020 | Volume 11 | Article 214
...
論文の公開元へ
